Jean-Baptiste Gibier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jean-Baptiste Gibier has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Arnaud Lionet
Department of Nephrology, Kidney Transplantation and Dialysis, Centre Hospitalier Universitaire Lille, Lille, France
2 shared publications - François Glowacki
Department of Nephrology, Kidney Transplantation and Dialysis, Centre Hospitalier Universitaire Lille, Lille, France
2 shared publications - Mehdi Maanaoui
Department of Nephrology, Kidney Transplantation and Dialysis, Centre Hospitalier Universitaire Lille, Lille, France
2 shared publications - Alexandre Loupy
INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, Université de Paris Cité, Paris, France
1 shared publication - Christelle Cauffiez
Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277—CANTHER—Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France
1 shared publication - Fariza Mezine
Université Paris Cité, Paris-Cardiovascular Research Center (PARCC), INSERM U970, Paris Institute for Transplantation and Organ Regeneration (PITOR), Paris, France
1 shared publication
Latest Publications
- Open Access
- 11 August 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (9) , e1986
Molecular Diagnosis of Early Equivocal Alloimmune Injury After Imlifidase Desensitization in a Kidney Transplant Recipient
Was not provided for this article.
- 11 August 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (9) , e1986
Open AccessMolecular Diagnosis of Early Equivocal Alloimmune Injury After Imlifidase Desensitization in a Kidney Transplant Recipient
Was not provided for this article.
- Open Access
- 16 February 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (3) , e1587
Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection
Background.: The benefit of extracorporeal photopheresis on the course of kidney transplant rejection is unknown. The aim of our study was to investigate the variations in transcriptomics on graft biopsies when extracorporeal photopheresis was used to treat chronic humoral rejection after kidney transplantation. Methods.: We retrospectively analyzed the mRNA expression of 770 genes of interest in graft biopsies performed before and after treatment. Eight patients received an average of 23 extracorporeal photopheresis sessions over 4 mo between the 2 biopsies. Results.: Transcriptomic analysis of the graft biopsies identified a significant (adjusted P < 0.05) increase in CAV1 mRNA in all patients and a significant decrease in CD19, IL21, PAX5, and SFTPA2 mRNAs in 7 of 8 patients. Conclusions.: In patients treated with extracorporeal photopheresis for chronic humoral rejection after renal transplantation, omic analysis of repeated biopsies shows a reduction in fibrotic and inflammatory transcriptomic biologicals markers.
- 16 February 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (3) , e1587
Open AccessExtracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection
Background.: The benefit of extracorporeal photopheresis on the course of kidney transplant rejection is unknown. The aim of our study was to investigate the variations in transcriptomics on graft biopsies when extracorporeal photopheresis was used to treat chronic humoral rejection after kidney transplantation. Methods.: We retrospectively analyzed the mRNA expression of 770 genes of interest in graft biopsies performed before and after treatment. Eight patients received an average of 23 extracorporeal photopheresis sessions over 4 mo between the 2 biopsies. Results.: Transcriptomic analysis of the graft biopsies identified a significant (adjusted P < 0.05) increase in CAV1 mRNA in all patients and a significant decrease in CD19, IL21, PAX5, and SFTPA2 mRNAs in 7 of 8 patients. Conclusions.: In patients treated with extracorporeal photopheresis for chronic humoral rejection after renal transplantation, omic analysis of repeated biopsies shows a reduction in fibrotic and inflammatory transcriptomic biologicals markers.